These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7878933)

  • 21. Mycophenolate mofetil in lung transplantation.
    Zuckermann A; Birsan T; Thaghavi S; Artemiou O; Kupilik N; Dekan G; Wolner E; Klepetko W
    Transplant Proc; 1998 Jun; 30(4):1514-6. PubMed ID: 9636616
    [No Abstract]   [Full Text] [Related]  

  • 22. The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).
    Laskow DA; Deierhoi MH; Hudson SL; Orr CL; Curtis JJ; Diethelm AG
    Transplantation; 1994 Feb; 57(4):640-3. PubMed ID: 8116055
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunosuppressive effect of mycophenolate mofetil with two different dosages in cadaveric renal transplantation: a short study.
    Wang X; Tang X; Xu D
    Transplant Proc; 1998 Nov; 30(7):3573-4. PubMed ID: 9838564
    [No Abstract]   [Full Text] [Related]  

  • 25. Mycophenolate mofetil for the transplanted kidney?
    Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients.
    Chueh SC; Huang CY; Lai MK
    Transplant Proc; 2000 Nov; 32(7):1901-2. PubMed ID: 11119992
    [No Abstract]   [Full Text] [Related]  

  • 27. One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation.
    Deierhoi MH; Sollinger HW; Diethelm AG; Belzer FO; Kauffman RS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):693-4. PubMed ID: 8438440
    [No Abstract]   [Full Text] [Related]  

  • 28. Living unrelated kidney donation: an underutilized resource?
    Ploeg RJ; Pirsch JD; Stegall MD; Armbrust MJ; Lorentzen DF; D'Alessandro AM; Knechtle SJ; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1532-4. PubMed ID: 8442177
    [No Abstract]   [Full Text] [Related]  

  • 29. RS-61443: a new immunosuppressive agent.
    Young CJ; Sollinger HW
    Transplant Proc; 1994 Dec; 26(6):3144-6. PubMed ID: 7998096
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycophenolate mofetil for prevention of acute rejection.
    Winearls CG
    Lancet; 1995 Jul; 346(8969):253-4. PubMed ID: 7616828
    [No Abstract]   [Full Text] [Related]  

  • 31. One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation.
    Khosla UM; Martin JE; Baker GM; Schroeder TJ; First MR
    Transplant Proc; 1999; 31(1-2):274-5. PubMed ID: 10083105
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
    Thervet E
    Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
    [No Abstract]   [Full Text] [Related]  

  • 33. RS-61443 reverses acute renal allograft rejection in dogs.
    Platz KP; Bechstein WO; Eckhoff DE; Hullett DA; Sollinger HW
    Transpl Int; 1992; 5 Suppl 1():S542-3. PubMed ID: 14621871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil in the prevention of rejection after kidney transplantation.
    Kiehl MG
    Transplantation; 2000 Apr; 69(8):1753-4. PubMed ID: 10836400
    [No Abstract]   [Full Text] [Related]  

  • 35. RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection.
    Sollinger HW; Belzer FO; Deierhoi MH; Diethelm AG; Gonwa TA; Kauffman RS; Klintmalm GB; McDiarmid SV; Roberts J; Rosenthal JT
    Ann Surg; 1992 Oct; 216(4):513-8; discussion 518-9. PubMed ID: 1417199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current status of mycophenolate mofetil in pediatric renal transplantation.
    Tönshoff B
    Pediatr Transplant; 1999 Feb; 3(1):5-9. PubMed ID: 10359025
    [No Abstract]   [Full Text] [Related]  

  • 37. The Tricontinental Mycophenolate Mofetil Trial.
    Browne BJ
    Transplantation; 1996 Dec; 62(11):1697. PubMed ID: 8970635
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of antilymphocyte therapy on sensitized patients in renal transplantation.
    Santi S; Fop F; Segoloni G; Piccoli G
    Transplant Proc; 2001; 33(1-2):1090. PubMed ID: 11267204
    [No Abstract]   [Full Text] [Related]  

  • 39. Mycophenolate mofetil in the treatment of chronic rejection in renal transplantation: 3-year follow-up.
    Noronha IL; Oliveira AC; Abensur H; Romão JE; Araújo MR; Zatz R
    Transplant Proc; 2002 Mar; 34(2):491-3. PubMed ID: 12009601
    [No Abstract]   [Full Text] [Related]  

  • 40. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
    Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
    Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.